ArticleOncoTargets and therapy2020

Bilirubin Can Be Used as a Prognostic Factor for Lung Adenocarcinoma Patients with EGFR Mutations.

Yimeng Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.